These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19683124)

  • 1. Rifampin-containing regimens for community-associated skin infection: a hazard without known benefit.
    Miller LG; Boucher H
    Am J Emerg Med; 2009 Sep; 27(7):893-4. PubMed ID: 19683124
    [No Abstract]   [Full Text] [Related]  

  • 2. Elimination of a community-acquired methicillin-resistant Staphylococcus aureus infection in a nurse with atopic dermatitis.
    Roesch A; Linde HJ; Landthaler M; Vogt T
    Arch Dermatol; 2005 Dec; 141(12):1520-2. PubMed ID: 16365252
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of mild CA-MRSA skin infections: more complicated that it looks at a glance.
    Pérez A; Orta L; Pascual M; Padilla E; Mesquida X; González M; Huguet O
    Eur J Dermatol; 2012; 22(6):800-1. PubMed ID: 23178963
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Hyun DY; Mason EO; Forbes A; Kaplan SL
    Pediatr Infect Dis J; 2009 Jan; 28(1):57-9. PubMed ID: 19057459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin, trimethoprim-sulfamethoxazole, and rifampin.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 1995 Sep; 9(3):747-67. PubMed ID: 7490442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S
    Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.
    Join-Lambert O; Coignard H; Jais JP; Guet-Revillet H; Poirée S; Fraitag S; Jullien V; Ribadeau-Dumas F; Thèze J; Le Guern AS; Behillil S; Leflèche A; Berche P; Consigny PH; Lortholary O; Nassif X; Nassif A
    Dermatology; 2011 Feb; 222(1):49-58. PubMed ID: 21109728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia--a rare but serious side effect of rifampicin.
    Shah NM; Venkatachalam S; Mehta Y; Balakrishnan C; Dubey SG; Mangat GK; Joshi VR
    J Assoc Physicians India; 1996 May; 44(5):359-60. PubMed ID: 9282598
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oral antibiotic therapy in the adult bacterial osteomyelitis: results after two years of follow-up].
    Javaloyas de Morlius M; Monreal Portella M
    Med Clin (Barc); 1999 Oct; 113(13):488-9. PubMed ID: 10604172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients.
    Ribera E; Pou L; Fernandez-Sola A; Campos F; Lopez RM; Ocaña I; Ruiz I; Pahissa A
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3238-41. PubMed ID: 11600390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin-associated segmental necrotizing glomerulonephritis in staphylococcal endocarditis.
    Wiggins KJ; Galanos JW; Hill PA; Scott KV; Langham RG
    J Nephrol; 2007; 20(4):489-94. PubMed ID: 17879217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognizing, understanding, and treating critical community acquired methicillin-resistant Staphylococcus aureus infection in children.
    Carcillo JA; Castillo L; Thomas J; Kissoon N
    Pediatr Crit Care Med; 2009 May; 10(3):405-7. PubMed ID: 19433946
    [No Abstract]   [Full Text] [Related]  

  • 14. Boil to sepsis case of community acquired MRSA.
    Gayathri S; Indira J
    Indian Pediatr; 2009 Jun; 46(6):537-8. PubMed ID: 19556666
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic community-acquired Acinetobacter pneumonia that responded slowly to rifampicin in the anti-tuberculous regime.
    Sharma A; Shariff M; Thukral SS; Shah A
    J Infect; 2005 Oct; 51(3):e149-52. PubMed ID: 16230195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome associated with acute neurobrucellosis.
    Namiduru M; Karaoglan I; Yilmaz M
    Int J Clin Pract; 2003 Dec; 57(10):919-20. PubMed ID: 14712899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin as treatment for pruritus in malignant cholestasis: an example of an improper indication for anti-infective drugs.
    Castagnola E; Viscoli C
    Support Care Cancer; 1999 May; 7(3):160. PubMed ID: 10335936
    [No Abstract]   [Full Text] [Related]  

  • 18. Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation: safety in breastfeeding infants.
    Mitrano JA; Spooner LM; Belliveau P
    Pharmacotherapy; 2009 Sep; 29(9):1103-9. PubMed ID: 19698015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen.
    Mistry RD; Schwab SH; Treat JR
    Pediatr Emerg Care; 2009 Aug; 25(8):519-22. PubMed ID: 19687711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.
    Tattevin P; Revest M; Dupont M; Arvieux C; Michelet C
    Clin Infect Dis; 2003 Jan; 36(1):127-8. PubMed ID: 12491218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.